Therapie mit kardialen elektronischen implantierbaren Devices: CME: Zertifizierte Fortbildung

Cardiac device therapy provides not only treatment options for bradyarrhythmia but also advanced treatment for heart failure and preventive measures against sudden cardiac death. In heart failure treatment it enables synergistic reverse remodelling and reduces pharmacological side effects. Cardiac r...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Kuschyk, Jürgen (VerfasserIn) , Sattler, Katherine (VerfasserIn) , Fastenrath, Fabian (VerfasserIn) , Rudic, Boris (VerfasserIn) , Akın, Ibrahim (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Deutsch
Veröffentlicht: June 2024
In: Herz
Year: 2024, Jahrgang: 49, Heft: 3, Pages: 233-246
ISSN:1615-6692
DOI:10.1007/s00059-024-05246-1
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1007/s00059-024-05246-1
Verlag, lizenzpflichtig, Volltext: https://link.springer.com/article/10.1007/s00059-024-05246-1
Volltext
Verfasserangaben:Jürgen Kuschyk, Katherine Sattler, Fabian Fastenrath, Boris Rudic, Ibrahim Akin
Beschreibung
Zusammenfassung:Cardiac device therapy provides not only treatment options for bradyarrhythmia but also advanced treatment for heart failure and preventive measures against sudden cardiac death. In heart failure treatment it enables synergistic reverse remodelling and reduces pharmacological side effects. Cardiac resynchronization therapy (CRT) has revolutionized the treatment of reduced left ventricular ejection fraction (LVEF) and left bundle branch block by decreasing the mortality and morbidity with improvement of the quality of life and resilience. Conduction system pacing (CSP) as an alternative method of physiological stimulation can improve heart function and reduce the risk of pacemaker-induced cardiomyopathy. Leadless pacers and subcutaneous/extravascular defibrillators offer less invasive options with lower complication rates. The prevention of infections through preoperative and postoperative strategies enhances the safety of these therapies.
Beschreibung:Online veröffentlicht: 6. Mai 2024
Gesehen am 27.01.2025
Beschreibung:Online Resource
ISSN:1615-6692
DOI:10.1007/s00059-024-05246-1